Abstract PO-042: A multimodal analysis in breast cancer: Revealing metabolic heterogeneity using DESI-MS imaging with Laser-microdissection coupled transcriptome approach

Author(s):  
Emine Kazanc ◽  
Evi Karali ◽  
Vincen Wu ◽  
Paolo Inglese ◽  
James McKenzie ◽  
...  
2013 ◽  
Vol 31 (15_suppl) ◽  
pp. 1132-1132
Author(s):  
Diana L. Caragacianu ◽  
Xiaohui Liu ◽  
Isaiah Norton ◽  
Jennifer Ide ◽  
Andrea Richardson ◽  
...  

1132 Background: Routine intra-operative distinction between normal breast tissue and tumor is currently not possible in breast conserving surgery (BCS). This limitation affects the success of surgery, resulting in up to 40% requiring more than one operative procedure. Desorption electrospray ionization mass spectrometry (DESI MS) has been successfully used to discriminate between normal and cancerous human tissues from anatomical sites such as the liver and brain. The aim of this proof of concept study was to determine the feasibility of using DESI MS imaging for tissue identification and differentiation of breast cancer versus normal tissue. Methods: DESI MS imaging was carried out on 14 human invasive breast cancer samples. Breast cancer and adjacent normal paired human tissue sections (margin of tumor, 2cm and 5 cm from tumor) from 14 patients undergoing mastectomy were flash frozen in liquid nitrogen, sectioned, and thaw mounted to glass slides. All samples were imaged using DESI MS at 200 μm imaging resolution. DESI MS images were overlaid and compared with hematoxylin and eosin (H&E) images of the same sections. Results: Discrimination between cancer and adjacent normal tissue was achieved on the basis of the spatial distribution and varying intensities of particular fatty acids and lipid species. Several fatty acids such as oleic acid (m/z 281) and arachidonic acid (m/z 303) displayed much greater signal intensities in the cancer specimen compared to low or undetectable intensities in normal tissue. The cancer margins delineated by the DESI MS images of these molecules were consistent with H and E images of the tumor edge. Cancerous tissue was distinguished from normal tissue based on the qualitative assessment of molecular signatures and the distinction was in agreement with expert histopathology evaluation in 85% of samples. Conclusions: Our findings offer proof of concept that examination and classification of breast normal and cancer tissue by mass spectrometry imaging is highly accurate. The results are encouraging for development of a MS-based method that could be utilized intra-operatively for rapid detection of residual cancer tissue in the lumpectomy bed in BCS.


Epigenomics ◽  
2021 ◽  
Vol 13 (16) ◽  
pp. 1247-1268
Author(s):  
Yajie Zhao ◽  
Chunrui Pu ◽  
Dechuang Jiao ◽  
Jiujun Zhu ◽  
Xuhui Guo ◽  
...  

Aim: To develop an approach to characterize and classify triple-negative breast cancer (TNBC) tumors based upon their essential amino acid (EAA) metabolic activity. Methods: We performed bioinformatic analyses of genomic, transcriptomic and clinical data in an integrated cohort of 740 TNBC patients from public databases. Results: Based on EAA metabolism-related gene expression patterns, two TNBC subtypes were identified with distinct prognoses and genomic alterations. Patients exhibiting an upregulated EAA metabolism phenotype were more prone to chemoresistance but also expressed higher levels of immune checkpoint genes and may be better candidates for immune checkpoint inhibitor therapy. Conclusion: Metabolic classification based upon EAA profiles offers a novel biological insight into previously established TNBC subtypes and advances current understanding of TNBC’s metabolic heterogeneity.


2020 ◽  
Vol 117 (4) ◽  
pp. 2092-2098 ◽  
Author(s):  
Ferdia A. Gallagher ◽  
Ramona Woitek ◽  
Mary A. McLean ◽  
Andrew B. Gill ◽  
Raquel Manzano Garcia ◽  
...  

Our purpose is to investigate the feasibility of imaging tumor metabolism in breast cancer patients using 13C magnetic resonance spectroscopic imaging (MRSI) of hyperpolarized 13C label exchange between injected [1-13C]pyruvate and the endogenous tumor lactate pool. Treatment-naïve breast cancer patients were recruited: four triple-negative grade 3 cancers; two invasive ductal carcinomas that were estrogen and progesterone receptor-positive (ER/PR+) and HER2/neu-negative (HER2−), one grade 2 and one grade 3; and one grade 2 ER/PR+ HER2− invasive lobular carcinoma (ILC). Dynamic 13C MRSI was performed following injection of hyperpolarized [1-13C]pyruvate. Expression of lactate dehydrogenase A (LDHA), which catalyzes 13C label exchange between pyruvate and lactate, hypoxia-inducible factor-1 (HIF1α), and the monocarboxylate transporters MCT1 and MCT4 were quantified using immunohistochemistry and RNA sequencing. We have demonstrated the feasibility and safety of hyperpolarized 13C MRI in early breast cancer. Both intertumoral and intratumoral heterogeneity of the hyperpolarized pyruvate and lactate signals were observed. The lactate-to-pyruvate signal ratio (LAC/PYR) ranged from 0.021 to 0.473 across the tumor subtypes (mean ± SD: 0.145 ± 0.164), and a lactate signal was observed in all of the grade 3 tumors. The LAC/PYR was significantly correlated with tumor volume (R = 0.903, P = 0.005) and MCT 1 (R = 0.85, P = 0.032) and HIF1α expression (R = 0.83, P = 0.043). Imaging of hyperpolarized [1-13C]pyruvate metabolism in breast cancer is feasible and demonstrated significant intertumoral and intratumoral metabolic heterogeneity, where lactate labeling correlated with MCT1 expression and hypoxia.


2019 ◽  
Vol 79 ◽  
pp. 186-194 ◽  
Author(s):  
Onésia Cristina Oliveira-Lima ◽  
Juliana Carvalho-Tavares ◽  
Marcella F. Rodrigues ◽  
Marcus V. Gomez ◽  
A.C.P. Oliveira ◽  
...  
Keyword(s):  

2015 ◽  
Vol 27 (1) ◽  
pp. 184
Author(s):  
A. K. Jarmusch ◽  
C. R. Ferreira ◽  
L. S. Eberlin ◽  
V. Pirro

Understanding the role of lipid metabolism in ovarian physiology is crucial for the progression of reproductive biotechnology. The aim in this work was to explore the lipid composition and dynamics of ovarian tissue, specifically the stroma, follicles, and corpora lutea. Desorption electrospray ionization–mass spectrometry (DESI-MS), an ambient ionization technique, was applied in this investigation, acquiring chemical and spatial information simultaneously. A morphologically-friendly solvent, dimethylformamide-acetonitrile (1 : 1), was used for DESI-MS imaging which allowed for ovarian lipid characterisation and subsequent staining (hematoxylin and eosin) providing morphological information. By this approach, regions-of-interest (ROI) were selected from bovine (n = 8), swine (n = 3), and mice (n = 5) ovaries (including pre-pubescent and cycling adults) based on the stained morphological structures. ROI for stroma (n = 54), follicles (n = 89), and corpora lutea (n = 61) were selected and chemically profiled. Tissue sections (20 μm) were thaw mounted onto glass microscope slides and stored at –80°C until analysis. A linear ion trap mass spectrometer equipped with a custom DESI-MS imaging stage was operated in the negative ion mode (m/z 200 to 1000). A 300 × 300 µm pixel size was used in DESI-MS imaging of ovarian tissue. Hyperspectral DESI images were reconstructed and processed by principal component analysis (PCA) that allowed visualisation of relationships among spatial (i.e. morphology) and chemical features. Ions indicated by PCA were analysed using univariate analysis (ANOVA), supporting the significance of particular lipids between morphological structures, e.g. adrenic acid (P = 1.7 × 10–8) and m/z 836 (P = 8.9 × 10–9) between corpora lutea and follicles. All morphological structures could be differentiated by multivariate statistics (>90% prediction rate) independent of the species, indicating conserved lipid constitution. Smaller differences in the lipid profiles were noted between species, poly-ovulatory and mono-ovulatory species, and reproductive maturation. A large variety and abundance of lipids was observed in corpora lutea and follicles, where steroidogenesis is a prominent physiological activity. Additional insight into ovarian physiology was gained with the detection of arachidonic and adrenic acid. The spatial relationship of arachidonic and adrenic acid with the corpora lutea – the former is a known prostaglandin precursor and key signalling molecule in steroidogenesis regulation and the latter is metabolized in the prostaglandin pathway by the same enzymes – suggests the latter may also have a role in steroidogenesis regulation, previously unseen in ovarian physiology. DESI-MS imaging with morphologically-driven statistical analysis proved efficient in relating and interpreting the chemical and morphological features. This methodology can by further applied to unravel complex ovarian-related physiological mechanisms and to other physiological and physiopathological models.


Neuroscience ◽  
2020 ◽  
Vol 426 ◽  
pp. 1-12 ◽  
Author(s):  
Dryelle L.R. Severiano ◽  
Onésia C. Oliveira-Lima ◽  
Géssica A. Vasconcelos ◽  
Bruno Lemes Marques ◽  
Gustavo Almeida de Carvalho ◽  
...  

Cancers ◽  
2021 ◽  
Vol 13 (18) ◽  
pp. 4699
Author(s):  
Marina Fukano ◽  
Morag Park ◽  
Geneviève Deblois

Breast cancer progression is characterized by changes in cellular metabolism that contribute to enhanced tumour growth and adaptation to microenvironmental stresses. Metabolic changes within breast tumours are still poorly understood and are not as yet exploited for therapeutic intervention, in part due to a high level of metabolic heterogeneity within tumours. The metabolic profiles of breast cancer cells are flexible, providing dynamic switches in metabolic states to accommodate nutrient and energy demands and further aggravating the challenges of targeting metabolic dependencies in cancer. In this review, we discuss the intrinsic and extrinsic factors that contribute to metabolic heterogeneity of breast tumours. Next, we examine how metabolic flexibility, which contributes to the metabolic heterogeneity of breast tumours, can alter epigenetic landscapes and increase a variety of pro-tumorigenic functions. Finally, we highlight the difficulties in pharmacologically targeting the metabolic adaptations of breast tumours and provide an overview of possible strategies to sensitize heterogeneous breast tumours to the targeting of metabolic vulnerabilities.


Sign in / Sign up

Export Citation Format

Share Document